MedPath

Australian Stroke Clinical Registry - LIfe after Stroke Tailored Support (A-LISTS) study

Not Applicable
Recruiting
Conditions
Stroke
Stroke - Ischaemic
Stroke - Haemorrhagic
Registration Number
ACTRN12622001015730
Lead Sponsor
The Florey Institute of Neuroscience and Mental Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Must meet the agreed criteria for ‘high levels of unmet health needs’ provisionally defined as an extreme problem in any EQ5D domain, or have an overall quality of life score of below 60 (Visual Analogue Scale, EQ5D) self-report on the Australian Stroke Clinical Registry follow-up survey conducted between 90-180 days after stroke and will:
i) have indicated a willingness to be contacted for further research on the Australian Stroke Clinical Registry follow-up survey conducted between 90-180 days after stroke;
ii) be aged 18 years and above;
iii) have a confirmed acute stroke;
iv) be living in the community in a private residence, (i.e., not hospital or high care residential aged care facility or other institution);
v) able to participate in English and provide informed consent via a self-report or appropriate proxy to assist.

Exclusion Criteria

i) Australian Stroke Clinical Registry registrants with a transient ischemic stroke (TIA) will be excluded as they are often managed in outpatient stroke services and should not have any residual impairments as the condition is not permanent
ii) Have a life threating illnesses and are unlikely to survive to the study endpoint (i.e. 12-14 weeks post randomisation).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of participants that completed the feasibility trial assessed by auditing the study database<br>[ 12-14 weeks post randomisation];The proportion of intervention participants that attended the follow-up service assessed by auditing the study database[ 12-14 weeks post randomisation];The proportion of participants (patients) satisfied with the follow-up service assessed through a survey and/or interview/focus group with questions designed specifically for this study[ 12-14 weeks post randomisation]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath